Skip to content. | Skip to navigation

Personal tools

You are here: Home / News / Container for news / Abbott and Galapagos Announce Collaboration for Novel Oral Therapy

Abbott and Galapagos Announce Collaboration for Novel Oral Therapy

February 29, 2012 – Abbott and Galapagos have entered into a global collaboration to develop and commercialize an oral, next-generation JAK1 inhibitor in Phase II development with the potential to treat multiple autoimmune diseases.

Document Actions

Submit a news item!

News

Partners in the Cluster can submit news items to be circulated widely via the homepage of the Amsterdam BioMed Cluster.

Or add us to your mailing list for press releases: info[at]amsterdambiomed.nl

Organisations directory

Find your life sciences partner in the Amsterdam BioMed Cluster

Find your life sciences partner in the Amsterdam BioMed Cluster